News about Global Pharma

Alumis and Kaken Pharmaceutical to Develop ESK-001 in Dermatology in Japan

Under the terms of the agreement, Alumis will receive USD 40 million in upfront and near-term co-development payments from 2025 to 2026, with the potential to earn up to approximately USD 140 million in additional payments based on the achievement of milestones, and field option payments.

Global Pharma | 28/03/2025 | By Aishwarya |  451

ENTOD and Infigo Eyecare Hospitals to Revolutionise Under-Eye Aesthetics

Periorbital hyperpigmentation (POH) affects a significant portion of the population, with prevalence rates reaching up to 30 percent in India, particularly in individuals with darker skin tones.

Global Pharma | 28/03/2025 | By Aishwarya |  226

Primrose Bio Launches Prima RNApols ExTend to Enhance mRNA Vaccine Manufacturing

Prima ExTend outperforms traditional T7 polymerase by generating higher-quality mRNA with lower dsRNA, eliminating a common challenge in mRNA manufacturing and enhancing downstream purification efficiency.<br />

Global Pharma | 28/03/2025 | By Abha |  395

Mochida Seeks Japan's Approval for Tocilizumab Biosimilar in Partnership with AYUMI

This application is based on the results of a Phase I clinical study conducted in Japan with 110 healthy adults and a Phase III clinical study conducted in Japan with 368 patients with rheumatoid arthritis.

Global Pharma | 28/03/2025 | By Abha |  899

Shree Ganesh Remedies Embraces Sustainability With 2 MW Solar Plant in Gujarat

Gujarat-based pharmaceutical company Shree Ganesh Remedies Ltd. has commissioned a 2 MW solar power plant in Gujarat, covering 70 percent of its power needs. The project is expected to generate annual savings of approximately INR 2 crore in electricity expenses.

Global Pharma | 27/03/2025 | By Manvi |  295

Vasorum USA Receives FDA Approval for Celt ACD PLUS System with Blood Signal Technology

This next-generation device enhances the proven Celt ACD platform by providing physicians with a visual indicator for precise placement and closure, particularly beneficial in cases where ultrasound imaging is not available.

Global Pharma | 27/03/2025 | By Manvi |  225

aTyr Pharma Welcomes Dalia R. Rayes as Head of Commercial-Global Efzofitimod Franchise

Rayes brings over 25 years of experience building and leading commercial organizations at biotechnology and pharmaceutical companies, including leading rare disease product launches.

Global Pharma | 27/03/2025 | By Aishwarya |  666

Department of Pharmaceuticals Organises Industry Dialogue on PRIP Scheme in Bengaluru

The session provided detailed insights into the PRIP Scheme, along with other government initiatives promoting and enabling research innovation in the sector.

Global Pharma | 27/03/2025 | By Aishwarya |  342

Rarecells Appoints Dr. Neil Kurtz to its Board of Directors

Rarecells Inc. announces the appointment of Dr. Neil Kurtz to its Board of Directors. Dr. Kurtz, a renowned healthcare entrepreneur and executive, brings over 40 years of experience in the pharmaceutical, contract research, post-acute care, and medical diagnostic sectors.

Global Pharma | 26/03/2025 | By Manvi |  262

CDSCO Launches Digital Portal to Simplify Extension Process for Pharma MSMEs

This initiative is integrated into the Online National Drugs Licensing System (ONDLS) and follows the Health Ministry's notification granting an extension for compliance with updated Good Manufacturing Practices (GMP).

Global Pharma | 26/03/2025 | By Aishwarya |  488